导航
统计阶段 | 收益率 | 同类排名 |
---|---|---|
今年以来 | -11.60% | 903/950 |
近一周 | 4.16% | 192/956 |
近一月 | 18.46% | 61/954 |
近一季 | -11.73% | 890/943 |
近半年 | -11.08% | 737/910 |
近一年 | -17.01% | 486/859 |
近两年 | -13.99% | 373/746 |
近三年 | -15.42% | 208/558 |
成立以来 | 195.54% | - |
年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
2023 | 1.89% 75/952 |
9.44% 131/880 |
-2.00% 299/895 |
-4.87% 297/915 |
-0.15% 126/952 |
2022 | -20.75% 355/867 |
-12.49% 165/773 |
3.92% 583/806 |
-13.60% 494/845 |
0.87% 392/867 |
2021 | 13.95% 197/740 |
-1.98% 224/580 |
11.34% 322/659 |
5.49% 119/704 |
-1.02% 482/740 |
2020 | 30.84% 344/554 |
-3.16% 239/419 |
16.44% 330/466 |
9.67% 257/517 |
5.80% 423/554 |
2019 | 37.25% 238/410 |
29.59% 392/1149 |
-3.95% 647/1231 |
1.57% 286/390 |
8.56% 216/410 |
2018 | -27.00% 176/349 |
- - |
- - |
- - |
-13.39% 781/1080 |
2017 | 3.59% 162/285 |
- - |
- - |
- - |
- - |
2016 | 5.11% 17/205 |
- - |
- - |
- - |
- - |
2015 | 87.48% 3/151 |
- - |
- - |
- - |
- - |
2014 | 28.36% 9/24 |
- - |
- - |
- - |
- - |
2013 | 28.24% 5/21 |
- - |
- - |
- - |
- - |
2012 | 5.63% 79/157 |
- - |
- - |
- - |
- - |
基金名称 | 最新净值 | 季增长率 |
嘉实资源精选股票C | 2.9582 | 31.31% |
申万菱信量化精选A | 0.6559 | 26.65% |
鹏华医药 | 1.1201 | 24.15% |
融通产业趋势臻选股票 | 0.9626 | 23.03% |
泰达转型C | 2.2260 | 20.03% |
华商上游产业 | 2.4898 | 19.74% |
嘉实资源精选股票A | 3.0386 | 19.55% |
景顺沪港深 | 2.3200 | 19.26% |
北信瑞丰研究精选 | 1.4159 | 19.25% |
易方达医药生物股票C | 0.6522 | 18.05% |
申万量化 VS. () |
申万量化 VS. 前海开源公用事业股票(005669) |